Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis - Aix-Marseille Université Access content directly
Journal Articles Allergy Year : 2022

Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis

Giorgio Walter Canonica
Tim Harrison
  • Function : Author
Francesco Menzella
Renaud Louis
  • Function : Author
Borja Cosio
Njira Lugogo
  • Function : Author
Arjun Mohan
  • Function : Author
Annie Burden
  • Function : Author
Esther Garcia Gil
  • Function : Author

Dates and versions

hal-03800929 , version 1 (06-10-2022)

Identifiers

Cite

Giorgio Walter Canonica, Tim Harrison, Pascal Chanez, Francesco Menzella, Renaud Louis, et al.. Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis. Allergy, 2022, 77 (1), pp.150-161. ⟨10.1111/all.14902⟩. ⟨hal-03800929⟩
16 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More